Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 16Leukemia, Myeloid, Acute 16Myelodysplastic Syndromes 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma 9Leukemia 8Burkitt Lymphoma 8Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 6Hodgkin Disease 6Congenital Abnormalities 6Sarcoma 5Recurrence 5Neoplasms, Plasma Cell 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hematologic Neoplasms 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Central Nervous System Neoplasms 4Breast Neoplasms 4Wilms Tumor 3Retinoblastoma 3Neuroblastoma 3Neoplasm Metastasis 3Myeloproliferative Disorders 3Medulloblastoma 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Myelomonocytic, Juvenile 3

Interventions

thymoglobulin 1satralizumab 1rhoA GTP-Binding Protein 1eculizumab 1Sugars 1Steroids 1Prednisone 1Methylprednisolone 1Mesna 1Immunoglobulins 1Hizentra 1Hematopoietic Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Cyclophosphamide 1CK-2017357 1Bortezomib 1Amifampridine 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Myasthenia Gravis × Granulocyte Colony-Stimulating Factor × Clear all
NCT00424489 2018-08-31

Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis

Northwestern University

Phase 1 Terminated
9 enrolled 8 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡